2020 annual financial data
Solid Biosciences Inc. 2020 Operating margin
Solid Biosciences Inc. 2020 operating margin with verified reported values.
Direct answer
Operating margin was -2,592.56%.
Operating income was -86,462,000 USD and net income was -88,290,000 USD.
Operating cash flow was -56,599,000 USD.
Get free Solid Biosciences Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,335,000 USD
- Operating income
- -86,462,000 USD
- Net income
- -88,290,000 USD
- Operating cash flow
- -56,599,000 USD